Cell line · CVCL_YQ49
Papers30
15 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
1 to 20 of 30
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Investigating the Binding Mode of a Naphthol-Based Inhibitor Targeting SARS-CoV-2 Main Protease. | ChemMedChem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Genomics in containment: BSL-4-compatible workflows enable high-resolution genomic and transcriptomic analyses of Risk Group 4 viruses. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| miR-29a and miR-15b Modulate SARS-CoV-2 Beta and Omicron Infection in Human Lung Epithelial Cells. | Int J Mol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Antibody Transcytosis and Neutralizing Activity in Respiratory Epithelial Cells. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting peptidyl-arginine deiminase 4 suppresses SARS-CoV-2 replication and modulates the inflammatory response. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variant. | EBioMedicine | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike protein. | Elife | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Demultiplexing and barcode-specific adaptive sampling for nanopore direct RNA sequencing. | Nat Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| RBD design increases the functional antibody titers elicited by SARS-CoV-2 spike vaccination. | Antiviral Res | 2024 | Its Methods give the RRID and name the line | PubMed | |
| The flavonoid quercetin decreases ACE2 and TMPRSS2 expression but not SARS-CoV-2 infection in cultured human lung cells. | Biofactors | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion. | iScience | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Characterizing fitness and immune escape of SARS-CoV-2 EG.5 sublineage using elderly serum and nasal organoid. | iScience | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Pharmacokinetic and Pharmacodynamic Analysis of the 3CL Protease Inhibitor Ensitrelvir in a SARS-CoV-2 Infection Mouse Model. | Viruses | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization. | Cell Chem Biol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine. | EBioMedicine | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan. | Hum Vaccin Immunother | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Early Transcriptional Responses of Human Nasal Epithelial Cells to Infection with Influenza A and SARS-CoV-2 Virus Differ and Are Influenced by Physiological Temperature. | Pathogens | 2023 | Its Methods give the RRID and name the line | PubMed | |
| PubMed 36945583 | bioRxiv | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines. | Cell Rep | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization. | Clin Infect Dis | 2023 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_YQ49/papers